收藏切换
The role of liver asialoglycoprotein receptor 1 in metabolic diseases and the research progress of drugs
收藏切换
Min WU, Cun-yu FENG, Si-ming HAO, Lei LEI*, Yi HUAN*
Acta Pharmaceutica Sinica | 2026, 61(1) : 75 - 83
Less
收藏切换
Acta Pharmaceutica Sinica | 2026, 61(1): 75-83
• Reviews •
The role of liver asialoglycoprotein receptor 1 in metabolic diseases and the research progress of drugs
Full
Min WU, Cun-yu FENG, Si-ming HAO, Lei LEI*, Yi HUAN*
Affiliations
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2026-01-12 doi: 10.16438/j.0513-4870.2025-0731
Outline
收藏切换

In the field of prevention and treatment of metabolic diseases, liver is the core metabolic organ, and its functional status has an important impact on the development of diseases and the selection of treatment strategies. In recent years, with the in-depth study of liver receptor molecules, asialoglycoprotein receptor 1 (ASGR1) has gradually attracted attention because of its role in glycoprotein recognition, lipid metabolism regulation, and immune regulation. Although studies have suggested that ASGR1 dysfunction is closely related to a variety of metabolic diseases, it is still controversial to directly use ASGR1 as a therapeutic target, and further studies are needed to explore the feasibility and efficacy of ASGR1 as a liver target. On the other hand, ASGR1-mediated liver-targeted delivery systems have shown clinical application potential in multiple drug development. This article systematically reviews the physiological functions of ASGR1 and its research progress in metabolic diseases, focusing on its molecular regulatory mechanisms and drug application prospects, in order to provide reference for the diagnosis and treatment strategies of liver-related metabolic diseases.

asialoglycoprotein receptor 1  /  liver  /  cholesterol  /  lipid metabolism
吴敏, 冯存玉, 郝思铭, 雷蕾, 环奕. 肝脏去唾液酸糖蛋白受体1在代谢疾病中的作用及药物研究进展. 药学学报, 2026 , 61 (1) : 75 -83 . DOI: 10.16438/j.0513-4870.2025-0731
Min WU, Cun-yu FENG, Si-ming HAO, Lei LEI, Yi HUAN. The role of liver asialoglycoprotein receptor 1 in metabolic diseases and the research progress of drugs[J]. Acta Pharmaceutica Sinica, 2026 , 61 (1) : 75 -83 . DOI: 10.16438/j.0513-4870.2025-0731
Year 2026 volume 61 Issue 1
235
118
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0731
  • Receive Date:2025-06-26
  • Online Date:2026-09-21
  • Published:2026-01-12
Article Data
Affiliations
History
  • Received:2025-06-26
  • Revised:2025-09-01
Affiliations
    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0731
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT